LISDEXAMFETAMINE DIMESYLATE
These highlights do not include all the information needed to use LISDEXAMFETAMINE DIMESYLATE CHEWABLE TABLETS safely and effectively. See full prescribing information for LISDEXAMFETAMINE DIMESYLATE CHEWABLE TABLETS.LISDEXAMFETAMINE DIMESYLATE chewable tablets, for oral use, CIIInitial U.S. Approval: 2007
2653e72f-ebde-4245-9462-8b671b5d8a92
HUMAN PRESCRIPTION DRUG LABEL
Aug 25, 2023
Ascent Pharmaceuticals, Inc
DUNS: 080938961
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
lisdexamfetamine dimesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
lisdexamfetamine dimesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
lisdexamfetamine dimesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
lisdexamfetamine dimesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
lisdexamfetamine dimesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
lisdexamfetamine dimesylate
Product Details
FDA regulatory identification and product classification information